about
Inhibition of the diclofenac-induced cyclooxygenase-2 activity by paracetamol in cultured macrophages is not related to the intracellular lipid hydroperoxide tone.Priming innate immune responses to infection by cyclooxygenase inhibition kills antibiotic-susceptible and -resistant bacteria.Iloprost-induced nociception: determination of the site of anti-nociceptive action of cyclooxygenase inhibitors and the involvement of cyclooxygenase products in central mechanisms of nociception.In vitro cyclooxygenase activity assay in tissue homogenates.Activation of macrophage peroxisome proliferator-activated receptor-gamma by diclofenac results in the induction of cyclooxygenase-2 protein and the synthesis of anti-inflammatory cytokines.Human whole blood assay for rapid and routine testing of non-steroidal anti-inflammatory drugs (NSAIDs) on cyclo-oxygenase-2 activity.Prostanoid extraction and measurement.N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.Naltrexone Reverses Ethanol Preference and Protein Kinase C Activation in Drosophila melanogaster.Paracetamol-induced hypothermia is independent of cannabinoids and transient receptor potential vanilloid-1 and is not mediated by AM404Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE)Cyclooxygenase enzymes and their products in the carrageenan-induced pleurisy in ratsPharmacological targeting of the GABAB receptor alters Drosophila's behavioural responses to alcoholLoss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymes
P50
Q39687533-0615DAFB-AED5-4BC1-AE3D-27DFFCA9D2F0Q42314739-2A945BE4-11A3-4C85-B1DC-15B28C50420CQ42964959-DD94DFAF-6E99-41B1-A461-6F7CFF5AD572Q42964970-B79556CB-A0E6-481F-A053-CB6B4FEED612Q46121053-7155B694-BD04-4F94-8D78-C08015140098Q46402137-181E9FD1-5C45-4FBF-801F-8BAA617ED0B8Q48120961-5D1CC77A-9501-4B56-94F3-C1666C35EFB1Q48458046-249C1732-FADF-4B64-8B08-35BF16A197BCQ48555464-4B6CAB11-B703-4E9B-BDB3-589CB7F3A6F1Q52316995-F656D493-7332-46CC-B08A-49FC34EC3AB1Q84235807-EF7101DE-B44F-47B6-8593-59920D8C5FE8Q84343258-D8592D15-B778-43C8-A891-53A84C21D90BQ84580515-E2E79CF6-B076-4569-89AF-238F5217C328Q91565205-9E93D202-AC98-46E1-AAE6-D6D3A077A4A0Q92671180-514E4B0A-ED35-4D67-844F-2295C84687BE
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samir S Ayoub
@es
Samir S. Ayoub
@en
Samir S. Ayoub
@nl
Samir S. Ayoub
@sl
type
label
Samir S Ayoub
@es
Samir S. Ayoub
@en
Samir S. Ayoub
@nl
Samir S. Ayoub
@sl
prefLabel
Samir S Ayoub
@es
Samir S. Ayoub
@en
Samir S. Ayoub
@nl
Samir S. Ayoub
@sl
P106
P1153
6603872116
P21
P31
P496
0000-0003-2696-1785
P569
2000-01-01T00:00:00Z